Press Releases Nymox Pharmaceutical Corporation

Equities

NYMXF

BSP733981026

Market Closed - OTC Markets Other stock markets 20:40:05 10/05/2024 BST			5-day change	1st Jan Change
0.257 ^USD	+2.59%		-4.81%	-56.44%

2023	Nymox Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Nymox Pharmaceutical Corporation Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees – Court Awards Costs and Damages	03-27	GL
OTC F-Stocks Holiday Momentum Watchlist (TBRIF, PYRGF, NYMXF, MGDPF)	12-28	AQ
Nymox December 27 Message to Shareholders	12-27	GL
Nymox Reports California Court Issues Preliminary Injunction Against Defendants Lanham, Riley, Cutler and Others	11-30	GL
$250 Million Lawsuit Filed Against AscellaHealth by Nymox Accepted and Summons Issued in California Court	11-21	GL
Nymox: Q3 Earnings Snapshot	11-15	AQ
Nymox Pharmaceutical : MANAGEMENT’S DISCUSSION AND ANALYSIS - Form 6-K	11-15	PU
Nymox Pharmaceutical Corporation Sues AscellaHealth For $250 Million	11-09	GL
NYMOX REPORTS: Bahamian Court Today Suspends Order of October 3, 2023 Rendering Riley-Lanham and Accomplices Planned Vote Unauthorized	11-03	GL
NYMOX REPORTS NOTICE: California Court Issued A Temporary Restraining Order Enjoining Lanham, Riley, Cutler And Their Nevada Company After Court Hearing In Santa Ana, California, November 2, 2023	11-03	GL
NYMOX REPORTS NOTICE: California Court Issued A Temporary Restraining Order Enjoining Lanham, Riley, Cutler And Their Nevada Company After Court Hearing In Santa Ana, California, November 2, 2023	11-03	AQ
IMPORTANT MESSAGE TO NYMOX SHAREHOLDERS: NYMOX Cautions Against Unauthorized Improper Shareholder Meeting and Unauthorized Unregistered Solicitations	11-02	GL
IMPORTANT NOTICE: NYMOX Cautions Shareholders Not to Take Calls or Participate in Unauthorized Improper Shareholder Meeting	31/10/23	GL
Notice: Nymox Informs Its Shareholders Not to Take Calls or Participate in An Unauthorized and Improper Shareholder Meeting	27/10/23	GL
Nymox Reports New NYMOZARFEX Marketing Application is Accepted For Review	26/10/23	GL
Nymox Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH	25/09/23	GL
Nymox Reports Completion of $2 Million Private Placement	29/08/23	GL
Nymox Pharmaceutical : MANAGEMENT'S DISCUSSION AND ANALYSIS - Form 6-K	14/08/23	PU
Nymox Announces $2 Million Private Placement	02/08/23	GL
Nymox's 3-month ex-CFO was Awarded an Unauthorized and Undisclosed Treasury Directive for 100,000 Shares of Nymox Stock Without the Knowledge or Approval of the Nymox Board or Nymox’s CEO	31/07/23	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Nymox Pharmaceutical Corporation

Equities

NYMXF

BSP733981026

Press Releases

Filters